Medicaid Policy Matters -Webinar 5

From clinical breakthroughs to viral headlines, GLP-1 receptor agonists have transformed the healthcare landscape. But for Medicaid programs, the rapid growth of these treatments brings complex questions regarding adherence, safety, and sustainable coverage policy. 

Join the Center for Evidence-based Policy for a deep dive into real-world Medicaid claims data. We’re moving beyond the headlines to show you exactly how these medications are being used by Medicaid members and what that means for your state’s policy decisions. 

What You’ll Learn 

In this session, we will showcase findings from our latest proprietary research, focusing on three critical areas: 

• Utilization Trends: Who is using GLP-1s in the Medicaid population, and how has demand evolved over time? 
• Adherence and Persistence: Are members staying on therapy? We’ll examine discontinuation rates and the frequency of “switching” among different GLP-1 products. 
• Safety Benchmarks: How do adverse event rates compare among the GLP-1 products currently available to Medicaid members? 

This webinar was recorded live on Thursday, February 26, 2026. 

You can download a copy of the slides here!